ACVR2B
ACVR2B (activin A receptor type 2B, also known as ActR-IIB) is a transmembrane serine/threonine kinase that acts as a primary type 2 receptor for activin. It transduces the activin signal from the cell surface to the cytoplasm through type 1 receptors and SMAD proteins. Browse Assay Genie's current range of ACVR2B research reagents below, or read on for the biology behind the target.
ACVR2B is the type 2 component of the activin receptor complex, which it forms with type 1 serine/threonine kinase receptors such as ACVR1, ACVR1B or ACVR1c. Within this complex the type 2 receptor is the primary activin receptor, binding activin-A (INHBA), activin-B (INHBB) and inhibin-A (INHA-INHBA). Activin binding at the plasma membrane activates the type 2 kinase, which then phosphorylates and activates the type 1 receptor. The type 1 receptor in turn phosphorylates SMAD2 and SMAD3 on serine residues of their C-terminal tails. These are released into the cytoplasm, interact with SMAD4 and translocate to the nucleus to drive activin-induced transcription.
Signalling is subject to negative control. Inhibitory SMAD7, recruited to ACVR1B through FKBP1A, can prevent SMAD2 and SMAD3 from associating with the receptor complex, and inhibin-B antagonises activin signalling by binding the receptor via the IGSF1 inhibin coreceptor. Through this pathway ACVR2B is linked to neuronal differentiation and survival, hair follicle development and cycling, FSH production by the pituitary gland, wound healing, extracellular matrix production, immunosuppression and carcinogenesis. Activin is also thought to have a paracrine or autocrine role in ovarian follicular development.
Activins are dimeric growth and differentiation factors of the TGF-beta superfamily. Their receptors are transmembrane proteins with a cysteine-rich extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine/threonine kinase domain. Type 2 receptors are required for ligand binding and are considered constitutively active kinases, while type 1 receptors are essential for signalling. The ACVR2B gene encodes the activin A type IIB receptor, which has a 3- to 4-fold higher ligand affinity than the type IIA receptor. The protein belongs to the TKL Ser/Thr protein kinase family, TGFB receptor subfamily, and HGNC classes it among the type 2 receptor serine/threonine kinases and BMP receptors. Its previous name was activin A receptor, type IIB.
ACVR2B binds activin and activates type 1 receptors, which phosphorylate SMAD2 and SMAD3, making it a central component for studying this pathway.
The receptor is linked to FSH production by the pituitary gland and to a proposed role for activin in ovarian follicular development.
Activin signalling through this receptor regulates neuronal differentiation and neuronal survival, so it is relevant to neurobiology.
The pathway influences carcinogenesis, wound healing, extracellular matrix production and immunosuppression, which makes ACVR2B relevant to disease and repair studies.
ACVR2B is a type 2 activin receptor with serine/threonine kinase activity. It binds activin-A, activin-B and inhibin-A, then phosphorylates and activates a type 1 receptor. That receptor phosphorylates SMAD2 and SMAD3, which join SMAD4 and enter the nucleus to drive transcription.
The official name is activin A receptor type 2B. It is also written ActR-IIB, and its previous HGNC name was activin A receptor, type IIB. UniProt lists the protein as activin receptor type-2B. Its enzyme classification is EC 2.7.11.30, a receptor serine/threonine kinase.
Yes. Mouse and rat both have an ortholog named Acvr2b. The human gene belongs to the TGFB receptor subfamily of the TKL Ser/Thr protein kinase family. Check the datasheet of any product for its validated reactivity.
Other activin and TGF-beta family receptors that act alongside ACVR2B in the activin signalling pathway.
Gene and protein annotations from HGNC, NCBI Gene and UniProt Q13705; product specifications from Assay Genie datasheets.